| Artificial intelligence in early drug discovery enabling precision medicine F Boniolo, E Dorigatti, AJ Ohnmacht, D Saur, B Schubert, MP Menden Expert Opinion on Drug Discovery 16 (9), 991-1007, 2021 | 60 | 2021 |
| Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment C Falcomata, S Baerthel, SA Widholz, C Schneeweis, JJ Montero, ... Nature Cancer 3 (3), 318-336, 2022 | 56 | 2022 |
| Genetic Screens Identify a Context-Specific PI3K/p27Kip1 Node Driving Extrahepatic Biliary Cancer C Falcomatà, S Bärthel, A Ulrich, S Diersch, C Veltkamp, L Rad, F Boniolo, ... Cancer discovery 11 (12), 3158-3177, 2021 | 15 | 2021 |
| Epigenetic drug screening defines a PRMT5 inhibitor–sensitive pancreatic cancer subtype F Orben, K Lankes, C Schneeweis, Z Hassan, H Jakubowsky, L Krauß, ... JCI insight 7 (10), 2022 | 8 | 2022 |
| Xeno-hybrid bone graft releasing biomimetic proteins promotes osteogenic differentiation of hMSCs H Zhu, VH Blahnová, G Perale, J Xiao, F Betge, F Boniolo, E Filová, ... Frontiers in Cell and Developmental Biology 8, 619111, 2020 | 7 | 2020 |
| spongEffects: ceRNA modules offer patient-specific insights into the miRNA regulatory landscape F Boniolo, M Hoffmann, N Roggendorf, B Tercan, J Baumbach, ... Bioinformatics 39 (5), btad276, 2023 | 5 | 2023 |
| Prediction via similarity: Biomedical big data and the case of cancer models F Boniolo, G Boniolo, G Valente Philosophy & Technology 36 (1), 8, 2023 | 2 | 2023 |
| Conumee 2.0: enhanced copy-number variation analysis from DNA methylation arrays for humans and mice B Daenekas, E Pérez, F Boniolo, S Stefan, S Benfatto, M Sill, D Sturm, ... Bioinformatics 40 (2), btae029, 2024 | 1 | 2024 |
| Pancreatic cancer subtype-specific secreted factors determine the immunosuppressive tumor microenvironment S Bärthel, C Falcomatà, SA Widholz, A Toska, F Boniolo, C Schmitt, ... Cancer Research 82 (12_Supplement), 2514-2514, 2022 | | 2022 |
| Towards precision medicine: computational approaches for patient stratification and biomarker identification in oncology F Boniolo Technische Universität München, 2022 | | 2022 |
| Development of advanced modelling techniques for Raman based spectral data of bioprocesses F BONIOLO Politecnico di Milano, 2017 | | 2017 |
Benjamin SchubertGroup Leader, ICB@Helmholtz Center Munich在 helmholtz-muenchen.de 的电子邮件经过验证
